Nalgonda, India

Prapulla Kumar Palvai

This inventor holds 1 USPTO granted patent. Top assignee: Dr. Reddy's Laboratories, Incorporated. Active years: 2020.


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Prapulla Kumar Palvai: Innovator in Pharmaceutical Chemistry

Introduction

Prapulla Kumar Palvai is a notable inventor based in Nalgonda, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for drug synthesis. His work is characterized by a focus on innovative methods that enhance the efficiency and effectiveness of pharmaceutical compounds.

Latest Patents

Prapulla Kumar Palvai holds a patent for a process for the preparation of eribulin and its intermediates. This patent, which is crucial for the synthesis of halichondrin B analogues, outlines a method for preparing tetrahydrofuran compounds and other related intermediates. The patent is essential for the production of eribulin, a drug used in cancer treatment, and demonstrates his expertise in pharmaceutical innovation. He has 1 patent to his name.

Career Highlights

Prapulla Kumar Palvai is currently employed at Dr. Reddy's Laboratories, Incorporated, a leading pharmaceutical company known for its commitment to research and development. His role at the company allows him to apply his innovative ideas in a practical setting, contributing to the advancement of pharmaceutical products.

Collaborations

Some of his notable coworkers include Kumar Sarvesh and Debjit Basu. Their collaboration fosters a creative environment that encourages the development of new ideas and solutions in the pharmaceutical industry.

Conclusion

Prapulla Kumar Palvai is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug synthesis. His contributions, particularly in the preparation of eribulin, highlight his innovative spirit and dedication to improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…